The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 16.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 83,311 shares of the medical device company's stock after selling 16,509 shares during the period. Segall Bryant & Hamill LLC's holdings in Cooper Companies were worth $7,027,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. City Holding Co. acquired a new stake in Cooper Companies in the first quarter valued at approximately $34,000. New Age Alpha Advisors LLC purchased a new stake in Cooper Companies in the fourth quarter valued at approximately $38,000. Covestor Ltd boosted its position in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC raised its stake in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock valued at $61,000 after acquiring an additional 664 shares during the period. Finally, HM Payson & Co. raised its position in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after buying an additional 532 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on COO shares. Loop Capital set a $100.00 price objective on Cooper Companies in a report on Tuesday, June 17th. Piper Sandler reissued an "overweight" rating and set a $105.00 target price (down previously from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. Wall Street Zen downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Finally, Mizuho dropped their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus target price of $97.20.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $73.26 on Friday. The firm has a market cap of $14.65 billion, a PE ratio of 35.56, a price-to-earnings-growth ratio of 1.77 and a beta of 0.99. The business has a fifty day moving average of $74.23 and a 200-day moving average of $82.18. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to analysts' expectations of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.85 earnings per share. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.